Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ActinogenMed
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ActinogenMed
-
View our Quarterly Update Report & App 4C for 3 month 31 Dec 2019. “…We’re advancing the development of trial proposals to align with
#Actinogen’s strategic plans & expect a number of clinical studies to initiate during the year ahead” said@BillKetelbey http://bit.ly/37vGrXSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A great presentation at Sachs 3rd Annual Neuroscience Innovation Forum in San Francisco with Dr Bill Ketelbey providing a company update and latest Xanamem developments
#Sachs_NIF@billketelbey$ACW#biotech#alzheimers#investorspic.twitter.com/14IwRiSJR5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are delighted to be at
#JPMWeek. This is a great opportunity to update on latest#Xanamem developments. Xanamem has been demonstrated to be an efficacious, brain penetrant & appropriately safe oral drug, with clinical results in line with its intended mechanism of action.pic.twitter.com/DwTYK2E2N7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#SACHS_NIF &#JPM2020 Week provides#Actinogen with an excellent opportunity to update the pharmaceutical industry & major global investors interested in Neuroscience on the compelling results achieved with XanaHES, & the expanded#Xanamem dataset generated during 2019.$ACWpic.twitter.com/2qDxWyMRNb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Actinogen is looking forward to present at#SACHS_NIF and participate in partnering meetings during#JPM2020 week in San Francisco. Contact info@actinogen.com.au if interested in meeting.$ACW@billketelbey#xanamem#JPM20#biotech#investor https://actinogen.com.au/wp-content/uploads/2020/01/20200108-ASX-2017870-Actinogen-at-SACHS-Forum-JP-Morgan-week.pdf …pic.twitter.com/ZfNhsMipLU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Actinogen Medical proslijedio/la je Tweet
Looking forward to hosting the Advances in Alzheimer’s & Other Cognitive Disorders Panel during our 3rd Annual
#Sachs_NIF Forum in San Francisco on 12th January 2020. Reserve your ticket now. More info at: https://is.gd/m4TGmU pic.twitter.com/cdVcHtgbna
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Actinogen Medical proslijedio/la je Tweet
Dr. Bill Ketelbey is a highly experienced and successful healthcare, biotech and pharmaceutical industry professional, with more than 30 years’ experience in the sector. Meet Bill at
#Sachs_NIF More info at: https://is.gd/m4TGmU pic.twitter.com/evObcHBbUI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Actinogen Medical proslijedio/la je Tweet
We're proud to include
#InternationalWomensDay@womensday as the letter I this year! We featured interviews with two brilliant women in neuroscience,@SelinaWray and Tamara Miller@ActinogenMed, which both proved to be very popular: http://bit.ly/2E31C6t#BalanceForBetterHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2019 has been a momentous year for
#Actinogen. We are pleased to provide an end-of-year review and an outlook update from@billketelbey.#cortisol#Xanamem$ACW#alzheimers#schizophrenia#diabetes https://actinogen.com.au/wp-content/uploads/2019/12/20191218-ASX-2013043-Review-of-2019-and-outlook.pdf …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Executive interview – Actinogen Medical CEO
@BillKetelbey provides an update on recent developments, R&D progress and expected newsflow#Xanamem#cortisol$ACW#clinicaltrialshttps://www.edisongroup.com/edison-tv/executive-interview-actinogen-medical-2/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Actinogen Medical proslijedio/la je Tweet
Great
@ABCnews piece highlighting the trials and companies "giving [#Alzheimer's] patients hope of a better life” featuring@ActinogenMed and@billketelbey. Report by@sophiescott2 &@brookewylie. See here - https://ab.co/37ywJV9#ausbio#clientHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Xanamem aims to treat#Alzheimers by blocking excess stress hormone#cortisol. “#Actinogen's research is promising & in our recent XanaHES study,#cognition improved rapidly & persisted.” said@BillKetelbey. Watch@sophiescott2 tonight#abc730 https://ab.co/2XHKlc8@ABCNewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read more in our newsletter, for a company update & the great progress made with the development of
#Xanamem & with our ongoing studies, on the back of recent outstandingly positive XanaHES results http://bit.ly/2r80xr3@billketelbey#cortisol$ACW#clinicaltrials#alzheimersHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Got 90 seconds? Listen to Actinogen Medical CEO Dr
@billketelbey tell us about the latest exciting trial results and upcoming newsflow#Investor$ACW#ASX@StockheadAU#Actinogenhttps://stockhead.com.au/stockhead-tv/video-90-seconds-with-dr-bill-ketelbey-actinogen-medical/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you miss
@billketelbey@AusMicrocap Investment Conference? Watch an#Actinogen update, with the path forward on next set of studies in#AlzheimersDisease,#cognitive impairment in#schizophrenia &#bipolar & other therapeutic areas@SmallCapsASX$ACWhttps://youtu.be/0qraMx8_4R8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Did you miss our presentation at
#AusMicrocap? Will Canty at@boardroom_media speaks to@billketelbey to get an update on#Actinogen, the recent breakthrough results from the XanaHES trial and the exciting pathway forward#xanamem#ASX#investor$ACW http://bit.ly/2N28Ay3Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Actinogen Medical proslijedio/la je Tweet
http://Boardroom.Media CEO Will Canty speaks to
@billketelbey, Managing Director of@ActinogenMed, at the 10th Annual@AusMicrocap Investment Conference to get an update of what$ACW has been up to. Watch the full interview through the link below. https://www.boardroom.media/broadcast-single/5db92756e91cf4152145e927 …pic.twitter.com/i0c506fuxF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Actinogen Medical proslijedio/la je Tweet
Bio-Link's
@CToouli will be representing@ActinogenMed at@AusBiotech’s annual conference,#AusBio19.pic.twitter.com/i7IqoFppLz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CEO
@billketelbey is excited to be presenting at#AusBioInv today. Come by Room 210/211 at 1345-1500 for a company update.#investor$ACW#ASX#biotech@AusBiotech#Actinogenhttps://twitter.com/ActinogenMed/status/1189409309026734085 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Actinogen Medical proslijedio/la je Tweet
Looking forward to this! Role play on derisking biotech messaging.
@AusBiotech#AusBio19@CToouli and panelpic.twitter.com/S8RzRah2FJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.